Hyperkalemia in chronic kidney disease: a focus on potassium lowering pharmacotherapy.
Erasmia SampaniMarieta TheodorakopoulouFotini IatridiPantelis A SarafidisPublished in: Expert opinion on pharmacotherapy (2023)
balance within the normal range with an excellent tolerability and no serious adverse events.